Our results in this study show that the knockdown of the JAK3-INSL3 fusion transcript in CTCL cell lines decreased phosphorylated JAK3 and its downstream STAT/NF-κb signaling pathways. The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.